XIIDRA Trademark Information

NOVARTIS AG

Anti-infectives; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal di...

This is a brand page for the XIIDRA trademark by NOVARTIS AG  in , , .

Write a review about a product or service associated with this XIIDRA trademark. Or, contact the owner NOVARTIS AG of the XIIDRA trademark by filing a request to communicate with the Legal Correspondent for licensing, use, and/or questions related to the XIIDRA trademark.

Status Update! On Thursday, November 19, 2020, status on the XIIDRA trademark changed to RESPONSE AFTER NON-FINAL ACTION - ENTERED.

On Monday, June 29, 2020, a U.S. federal trademark registration was filed for XIIDRA. The USPTO has given the XIIDRA trademark serial number of 79293316. The current federal status of this trademark filing is RESPONSE AFTER NON-FINAL ACTION - ENTERED. The correspondent listed for XIIDRA is Maury M. Tepper, III of Tepper & Eyster, PLLC, 3724 BENSON DR, RALEIGH NC 27609 . The XIIDRA trademark is filed in the category of Pharmaceutical Products . The description provided to the USPTO for XIIDRA is Anti-infectives; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma.

Word mark: XIIDRA
Status/Status Date:
RESPONSE AFTER NON-FINAL ACTION - ENTERED
11/19/2020
Serial Number: 79293316
Filing Date: 6/29/2020
Foreign Filing Deadline: Tuesday, December 29, 2020
 
Registration Number: NOT AVAILABLE
Registration Date: NOT AVAILABLE
Goods and Services: Anti-infectives; antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; pharmaceutical preparations acting on the central nervous system; pharmaceutical preparations and substances for the prevention and treatment of gastro-intestinal diseases; pharmaceutical preparations for the prevention and treatment of diseases and disorders of the metabolic system, the endocrine system, the musculo-skeletal system and the genitourinary system; pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for the prevention and treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma
Mark Description: The mark consists of the word "xiidra" in lower-case letters beneath a design suggestive of a stylized eye lens formed by a shaded crescent shape in between two upwardly curved lines.
Type Of Mark: TradeMark
Published For Opposition Date: N/A
Last Applicant/Owner: NOVARTIS AG
Mark Drawing Code: Drawing/Design + Words
Design Search:
Monocles and optical or spectacle lenses (Telecommunications, sound recording or reproduction equipment; photography, cinematography and optics - Photography, cinematography, optics) see more design...
Curved line(s), band(s) or bar(s) (Geometric figures and solids - Lines, bands, bars, chevrons and angles) see more design...
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
Tepper & Eyster, PLLC
3724 BENSON DR
RALEIGH NC 27609

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (005)
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
First Use Anywhere: : Not provided
First Use In Commerce: Not provided

Trademarkia is the largest search engine for U.S. trademarks. Each month hundreds of trademarks around the world are filed by licensed attorneys in the Trademarkia Network Law firms! You can register your trademark in 170+ countries in the world through Trademarkia Network Law firms.

Trademarkia-Network law firms can help you incorporate a business around your XIIDRA trademark in less than 5 minutes. Trademarkia makes the process easy and convenient, so start now!

Trademarkia.com is a free search engine of publicly available government records. Trademarkia.com is not a law firm and does not represent owners & correspondents listed on this page.

Trademark Document Retrieval >>

100% Satisfaction Guarantee protect your valuable brand now.

  • 1. Trademarkia Network law firm - #1 U.S. Trademark Filing from 2010 to now.
  • 2. Describe how your business or product is being used. Register your mark in 176+ countries. Starting $399/class + govt fees! Click here >>
  • 1. Top Global Specialist - Credibility and Experience!
  • 2. All processes will be performed in a timely manner.
Current Trademark Status:
11/19/2020
RESPONSE AFTER NON-FINAL ACTION - ENTERED
Correspondent Search:

Maury M. Tepper, III is a correspondent of XIIDRA trademark.

Current Overall Rating:
RatingRatingRatingRatingRating (0 review)
What You Can Do: